Next Milestone Ventures

Screen Shot 2019-07-18 at 1.21.05 PM

Calder Biosciences

Calder Biosciences is a vaccine immunogen design company that is developing novel RSV and universal Influenza subunit vaccines, both representing $ multi-billion market opportunities with mitigated clinical risk.



Christopher Marshall, Ph.D., Chief Executive Officer

Mark Yonda, Ph. D., Director of Research

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Next Milestone is a Program of